Resnick, Michael A.

The expanding universe of p53 targets

Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer

Cancer-related Molecular PathwaysGenomics and Chromatin Dynamics

Cited by 568

Genes required for ionizing radiation resistance in yeast

Bennett, C. B., Lewis, L. K., Karthikeyan, G., Lobachev, K. S., Jin, Y. H., Sterling, J. F., Snipe, J. R., & Resnick, M. A. (2001) · Nature Genetics

DNA Repair MechanismsFungal and yeast genetics research

Cited by 328

Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells

Menendez, D., Nguyen, T.-A., Freudenberg, J. M., Mathew, V. J., Anderson, C. W., Jothi, R., & Resnick, M. A. (2013) · Nucleic Acids Research

Cancer-related Molecular PathwaysGenomics and Chromatin Dynamics

Cited by 154

Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity

Resnick, M. A., & Inga, A. (2003) · Proceedings of the National Academy of Sciences

Cancer-related Molecular PathwaysGenomics and Chromatin Dynamics

Cited by 149

The Toll-like receptor gene family is integrated into human DNA damage and p53 networks

Menendez, D., Shatz, M., Azzam, K., Garantziotis, S., Fessler, M. B., & Resnick, M. A. (2011) · PLoS Genetics

Immune Response and InflammationCancer-related Molecular Pathways

Cited by 148

The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells

Shatz, M., Menendez, D., & Resnick, M. A. (2012) · Cancer Research

Immune Response and InflammationCancer-related Molecular Pathways

Cited by 143

Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53

Jordan, J. J., Menendez, D., Inga, A., Nourredine, M., Bell, D., & Resnick, M. A. (2008) · PLoS Genetics

Cancer-related Molecular PathwaysGenomics and Chromatin Dynamics

Cited by 103

Cohesin Is limiting for the suppression of DNA damage-induced recombination between homologous chromosomes

Covo, S., Westmoreland, J. W., Gordenin, D. A., & Resnick, M. A. (2010) · PLoS Genetics

DNA Repair MechanismsFungal and yeast genetics research

Cited by 89

The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes

Menendez, D., Inga, A., & Resnick, M. A. (2006) · Molecular and Cellular Biology

Cancer-related Molecular PathwaysCell death mechanisms and regulation

Cited by 81

Transcriptional functionality of germ line p53 mutants influences cancer phenotype

Monti, P., Ciribilli, Y., Jordan, J., Menichini, P., Umbach, D. M., Resnick, M. A., Luzzatto, L., Inga, A., & Fronza, G. (2007) · Clinical Cancer Research

Cancer-related Molecular PathwaysGenetic factors in colorectal cancer

Cited by 58

Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells

Menendez, D., Lowe, J. M., Snipe, J., & Resnick, M. A. (2016) · Oncotarget

Cancer-related Molecular PathwaysImmune Response and Inflammation

Cited by 31

p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways

Shatz, M., Shats, I., Menendez, D., & Resnick, M. A. (2015) · Oncotarget

Immune Response and InflammationCancer-related Molecular Pathways

Cited by 29

Etoposide-induced dna damage is increased in p53 mutants: identification of atr and other genes that influence effects of p53 mutations on top2-induced cytotoxicity

Menendez, D., Anand, J. R., Murphy, C. C., Bell, W. J., Fu, J., Slepushkina, N., Buehler, E., Martin, S. E., Lal-Nag, M., Nitiss, J. L., et al. (2022) · Oncotarget

Cancer therapeutics and mechanismsCancer-related Molecular Pathways

Cited by 22